GreenLight Biosciences or the RNA at every level
After genetic sequences and DNA, here comes RNA, the new flagship molecule in biotechnology that is supposed to solve agricultural and health problems. Companies in this field are flourishing. Among them is GreenLight Biosciences, a company that was on the verge of bankruptcy when it was bought by the investment fund Fall Line Capital.
EU: vitamins and additives produced by GMOs
European organic food processors say « no » to GMOs/NGTs
European organic food processors say “no” to GMOs/NGTs
GMO-derived enzymes used in food and feed
GMO-derived enzymes used in food and feed
Journal
Patents on living organisms: a growing appropriation
Journal
Patents on NGTs, between disputes and desire: the case of Crispr-Cas 9
Journal
Seed patents: the industry’s great manoeuvres
Patents on genetic sequences: excess and fragility
Some seed companies are opposing patents but…
